Aquatic Capital Management’s AngioDynamics ANGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-4,686
Closed -$60.2K 1348
2025
Q4
$60.2K Sell
4,686
-13,826
-75% -$171K ﹤0.01% 1240
2025
Q3
$207K Buy
+18,512
New +$179K ﹤0.01% 1089
2025
Q2
Sell
-726
Closed -$6.82K 1228
2025
Q1
$6.82K Sell
726
-6,650
-90% -$69.9K ﹤0.01% 1196
2024
Q4
$67.6K Sell
7,376
-20,324
-73% -$149K ﹤0.01% 1129
2024
Q3
$216K Buy
+27,700
New +$200K 0.01% 811
2023
Q1
Sell
-36,700
Closed -$505K 1238
2022
Q4
$505K Buy
36,700
+30,300
+473% +$422K 0.04% 499
2022
Q3
$131K Buy
+6,400
New +$141K 0.01% 697
2022
Q2
Sell
-1,100
Closed -$24K 1175
2022
Q1
$24K Sell
1,100
-1,200
-52% -$27.2K 0.04% 449
2021
Q4
$63K Buy
+2,300
New +$63.5K 0.12% 236

Other funds holding ANGO

Aquatic Capital Management's ANGO Position: Q1 2026 in Review

Aquatic Capital Management sold out of AngioDynamics (ANGO) in Q1 2026, closing a stake of 4,686 shares — an estimated $60.2K sold.

Aquatic Capital Management first reported a position in ANGO in Q4 2021 and held it in 9 quarters. The position peaked at $505K in Q4 2022. 147 funds tracked by Wall St. Rank hold ANGO as of Q1 2026.

  • Aquatic Capital Management reported no remaining AngioDynamics position as of Q1 2026 after selling out during the quarter.
  • Aquatic Capital Management sold 4,686 AngioDynamics shares in Q1 2026, an estimated $60.2K.
  • Aquatic Capital Management first reported a position in AngioDynamics in Q4 2021 and held it in 9 quarters.
  • Aquatic Capital Management's AngioDynamics position peaked at $505K in Q4 2022.
  • 147 funds tracked by Wall St. Rank held AngioDynamics as of Q1 2026.

Based on Aquatic Capital Management's 13F filing for Q1 2026, filed 15 May 2026.